Key Highlights
- Grey Matters Health said its Davie, Florida NovaScan clinic gained required United States accreditation.
- The company said the clinic also completed enrollment in Medicare and Medicaid programs.
- Grey Matters said the site will offer brain-focused positron emission tomography scans for Alzheimer’s detection.
Grey Matters Health Inc. (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF) said its flagship NovaScan Neuroimaging Clinics™ location in Davie, Florida has received accreditation and completed full enrollment in the United States Medicare and Medicaid programs.
The company described the steps as necessary for diagnostic imaging centres in the U.S. to be paid by Medicare and to negotiate “in-network” contracts with most private insurers. Grey Matters said the Davie clinic’s services will now be accessible to eligible Americans enrolled in Medicare and Medicaid, using established billing codes for brain positron emission tomography (PET) scans and the isotopes used in the imaging procedure.
This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
Grey Matters said the inaugural NovaScan location is in the HCA Florida University Medical Office Building in Davie, on the campus of the HCA Florida University Hospital. The company said it is the first U.S. clinic of its kind to provide brain-dedicated PET scans intended to aid in detecting Alzheimer’s Disease and other neurodegenerative diseases.
The release also said NovaScan locations will feature the U.S. Food and Drug Administration-cleared CareMiBrain™ system, which it described as a dedicated brain PET scanner with a chair-style design that does not require an integrated computed tomography component. Grey Matters said this design results in 25% less radiation exposure for patients, and that brain PET scans for beta-amyloid plaque detection associated with advancing Alzheimer’s are covered by Medicare, Medicaid and most private insurance for patients aged 65 and older.
“We have now reached the point in our commercialization pathway where we can begin introducing doctors and patients to the many features of our new clinic, including our brain dedicated PET scan technology,” said Christopher J. Moreau, Chief Executive Officer of Grey Matters Health Inc.
Grey Matters described itself as a Canadian healthcare company focused on providing brain-dedicated PET scanning services through a planned network of neuroimaging clinics in the U.S.
The original press release is available on stockhouse.com
s-13v4_h-14v4_i-15v4